De Novo Peptide Sequencing by Tandem Mass Spectrometry: When It Is Needed and How It Works
Introduction De Novo Peptide Sequencing by Tandem Mass Spectrometry is a sophisticated analytical proteomics technique used to determine the precise […]
Introduction De Novo Peptide Sequencing by Tandem Mass Spectrometry is a sophisticated analytical proteomics technique used to determine the precise […]
Generic Drug Development CDMO Cross-Border Drug Development: One Testing Lab for Both FDA and Health Canada Submissions By Anusha Sinha
Peptide vs Small-Molecule CMC What Is the Difference Between a Peptide and a Small-Molecule Drug in Manufacturing? By Anusha Sinha
What Is the Difference Between a Peptide and a Small-Molecule Drug in Manufacturing? Read More »
Peptide CDMO Strategy United States vs. Overseas Peptide CDMOs: Should You Reshore Your Supply Chain? By Anusha Sinha • August
United States vs. Overseas Peptide CDMOs: Should You Reshore Your Supply Chain? Read More »
Introduction: A successful Dexamethasone ANDA Submission involves far more than demonstrating that a generic product contains the same active pharmaceutical
Regulatory Pathway for Dexamethasone ANDA Submission Read More »
Introduction The primary Difference Between Biosimilarity and Interchangeability lies in regulatory designation and pharmacy-level substitution rights rather than any variation
Introduction Achieving Extractables and Leachables (E&L) Compliance for a Dry Powder Inhaler intended for European Medicines Agency (EMA) approval demands
Bioanalytical Method Validation Selectivity and Specificity in Bioanalytical Method Validation: What They Mean and How to Demonstrate Them By Anusha